Log In
Print this Print this

GBS trivalent vaccine, GBS vaccine, Group B Streptococcus vaccine

  Manage Alerts
Collapse Summary General Information
Company Valneva SE
DescriptionVaccine against Group B Streptococcus
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationStreptococcus
Indication DetailsPrevent group B Streptococcus infections
Regulatory Designation
PartnerNovartis AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today